These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32527306)

  • 1. Is distance associated with tuberculosis treatment outcomes? A retrospective cohort study in Kampala, Uganda.
    Robsky KO; Hughes S; Kityamuwesi A; Kendall EA; Kitonsa PJ; Dowdy DW; Katamba A
    BMC Infect Dis; 2020 Jun; 20(1):406. PubMed ID: 32527306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of empiric treatment for pediatric tuberculosis, Kampala, Uganda, 2010-2015.
    Wobudeya E; Jaganath D; Sekadde MP; Nsangi B; Haq H; Cattamanchi A
    BMC Public Health; 2019 Apr; 19(1):446. PubMed ID: 31035984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home-Based and Facility-Based Directly Observed Therapy of Tuberculosis Treatment under Programmatic Conditions in Urban Tanzania.
    Mhimbira F; Hella J; Maroa T; Kisandu S; Chiryamkubi M; Said K; Mhalu G; Mkopi A; Mutayoba B; Reither K; Gagneux S; Fenner L
    PLoS One; 2016; 11(8):e0161171. PubMed ID: 27513331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to the MDR-TB intensive phase treatment protocol amongst individuals followed up at central and peripheral health care facilities in Uganda - a descriptive study.
    Mukasa J; Kayongo E; Kawooya I; Lukoye D; Etwom A; Mugabe F; Tweya H; Izizinga R; Mijumbi-Deve R
    Afr Health Sci; 2020 Jun; 20(2):625-632. PubMed ID: 33163023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 pandemic and other factors associated with unfavorable tuberculosis treatment outcomes-Almaty, Kazakhstan, 2018-2021.
    Gabdullina M; Maes EF; Horth RZ; Dzhazybekova P; Amanova GN; Zikriyarova S; Nabirova DA
    Front Public Health; 2023; 11():1247661. PubMed ID: 37808989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of rural residence and HIV infection on poor tuberculosis treatment outcomes in a large urban hospital: a retrospective cohort analysis.
    Adamu AL; Aliyu MH; Galadanci NA; Musa BM; Lawan UM; Bashir U; Abubakar I
    Int J Equity Health; 2018 Jan; 17(1):4. PubMed ID: 29310659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessibility to tuberculosis control services and tuberculosis programme performance in southern Ethiopia.
    Dangisso MH; Datiko DG; Lindtjørn B
    Glob Health Action; 2015; 8():29443. PubMed ID: 26593274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
    Kirirabwa NS; Kimuli D; DeJene S; Nanziri C; Birabwa E; Okello DA; Suarez PG; Kasozi S; Byaruhanga R; Lukoye D
    PLoS One; 2018; 13(12):e0208390. PubMed ID: 30566486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Unfavorable Outcomes of Tuberculosis in Korea: Implications for Patient-Centered Care in Tuberculosis Treatment.
    Hong HY; Park Y; Yong SH; Woo A; Leem AY; Lee SH; Chung KS; Lee SH; Kim SY; Kim EY; Jung JY; Park MS; Kim YS; Shin SJ; Kang YA
    J Korean Med Sci; 2024 Jan; 39(2):e4. PubMed ID: 38225780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and implementation challenges of using daily treatment regimens with an innovative adherence support tool among HIV-infected tuberculosis patients in Karnataka, India: a mixed-methods study.
    Thekkur P; Kumar AN; Chinnakali P; Selvaraju S; Bairy R; Singh AR; Nirgude A; Selvaraj K; Venugopal V; Shastri S
    Glob Health Action; 2019; 12(1):1568826. PubMed ID: 30712507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection modifies the relationship between distance to a health facility and treatment success rate for tuberculosis in rural eastern Uganda.
    Olupot B; Adrawa N; Bajunirwe F; Izudi J
    J Clin Tuberc Other Mycobact Dis; 2021 May; 23():100226. PubMed ID: 33732899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuation of tuberculosis treatment among children in the Kampala Capital City Authority health facilities: a mixed-methods study.
    Kibirige L; Izudi J; Okoboi S
    BMC Infect Dis; 2021 Jun; 21(1):511. PubMed ID: 34074268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic accessibility to public health facilities providing tuberculosis testing services at point-of-care in the upper east region, Ghana.
    Kuupiel D; Adu KM; Apiribu F; Bawontuo V; Adogboba DA; Ali KT; Mashamba-Thompson TP
    BMC Public Health; 2019 Jun; 19(1):718. PubMed ID: 31182068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. People living with HIV travel farther to access healthcare: a population-based geographic analysis from rural Uganda.
    Akullian AN; Mukose A; Levine GA; Babigumira JB
    J Int AIDS Soc; 2016; 19(1):20171. PubMed ID: 26869359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control.
    Kirenga BJ; Ssengooba W; Muwonge C; Nakiyingi L; Kyaligonza S; Kasozi S; Mugabe F; Boeree M; Joloba M; Okwera A
    BMC Public Health; 2015 Jan; 15():13. PubMed ID: 25604986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile and treatment outcomes of elderly patients with tuberculosis in Delhi, India: implications for their management.
    Patra S; Lukhmana S; Tayler Smith K; Kannan AT; Satyanarayana S; Enarson DA; Nagar RK; Marcel M; Reid T
    Trans R Soc Trop Med Hyg; 2013 Dec; 107(12):763-8. PubMed ID: 24189479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of geographic mobility among participants in facility- and community-based tuberculosis case finding in urban Uganda.
    Robsky KO; Isooba D; Nakasolya O; Mukiibi J; Nalutaaya A; Kitonsa PJ; Kamoga C; Baik Y; Kendall EA; Katamba A; Dowdy DW
    PLoS One; 2021; 16(5):e0251806. PubMed ID: 33989343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
    Ezati N; Lukoye D; Wampande EM; Musisi K; Kasule GW; Cobelens FG; Kateete DP; Joloba ML
    BMC Infect Dis; 2014 Dec; 14():703. PubMed ID: 25523472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary healthcare centers engagement in tuberculosis treatment in Ukraine.
    Geliukh E; Nabirova D; Davtyan K; Yesypenko S; Zachariah R
    J Infect Dev Ctries; 2019 Jul; 13(7.1):83S-88S. PubMed ID: 32065810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.